Four new "Investigator Initiated Clinical Trials" approved
The SNSF has made available 10 million francs for clinical trials initiated by researchers. The fourth IICT call will be launched at the beginning of July 2018.
With the programme Investigator Initiated Clinical Trials (IICT), the Swiss National Science Foundation (SNSF) is promoting clinical studies in under-researched areas that do not attract industry interest. In the 2017 call, the SNSF evaluated 32 proposals - four of them will receive grants worth a total amount of 10.4 million francs. The studies focus on leukaemia, paraplegia, strokes and skin transplants. Before the projects can get underway, they need to be approved by the cantonal ethics commissions and Swissmedic. The next call for the IICT programme will be launched at the beginning of July 2018.
Approved projects:
- Pierre-Yves Bochud, CHUV Lausanne
Improving the prevention of fungal infections in patients with Acute Myeloid Leukaemia by means of genetic risk factors - Thomas Kessler, Uniklinik Balgrist, Zürich
Electric stimulation of the tibial nerve to prevent problems in the urinary tract of paraplegic patients - Stefan Engelter, Felix Platter Spital Basel
Improving the rehabilitation of stroke patients with Levodopa, a drug used to treat Parkinson's disease - Clemens Maria Schiestl, Universitäts-Kinderklinik Zürich
New skin transplant techniques to treat serious burns in children and adults